Drug Shortage Report for OXY.IR
| Report ID | 176997 |
| Drug Identification Number | 02240131 |
| Brand name | OXY.IR |
| Common or Proper name | Oxycodone Hydrochloride Immediate Release Tablets |
| Company Name | PURDUE PHARMA |
| Market Status | MARKETED |
| Active Ingredient(s) | OXYCODONE HYDROCHLORIDE |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 60 |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2022-12-01 |
| Actual start date | 2022-12-01 |
| Estimated end date | 2023-03-21 |
| Actual end date | 2023-02-17 |
| Shortage status | Resolved |
| Updated date | 2023-02-18 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.